Caligan Partners LP 13D and 13G filings for Alimera Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-18 4:30 pm Sale |
2024-09-16 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 0 0.000% |
-17,635,154 (Position Closed) |
Filing |
| 2024-06-24 7:30 pm Unchanged |
2024-06-21 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 17,635,154 33.200% |
0 (Unchanged) |
Filing |
| 2023-08-03 4:30 pm Sale |
2023-08-01 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 17,635,154 33.100% |
-915,040,279,903 (-100.00%) |
Filing |
| 2023-05-18 5:24 pm Purchase |
2023-05-17 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 915,057,915,057 9.990% |
915,057,190,341 (+126264245.63%) |
Filing |
| 2023-03-28 5:00 pm Purchase |
2023-03-24 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 724,716 9.990% |
313,189 (+76.10%) |
Filing |
| 2022-05-25 5:18 pm Purchase |
2022-05-19 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 411,527 5.900% |
411,527 (New Position) |
Filing |